DISCLAIMER: This product is strictly for research use only. It is meant solely for laboratory testing and in vitro studies-not for use in or on humans or animals. All details provided on this site are for educational purposes. This item is not intended to be used as a drug, supplement, or cosmetic, and must not be misrepresented as such.
CJC-1295 (no DAC) + Ipamorelin (Blend)
CJC-1295 (no DAC) and Ipamorelin are studied together for their potential to enhance natural growth hormone release through dual pathways—mimicking the body’s physiologic rhythm without impacting cortisol or prolactin.
Quantity: 1
All peptides arrive in powdered form for stability.
Third-Party Verified Purity
Each batch is tested and certified to meet or exceed 99% purity standards.
Made in the USA
Produced in United States WHO/GMP and ISO 9001:2015 certified facilities.
Rigorous Quality Control
Double-tested to ensure the highest quality for the most effective research.
What is CJC-1295 (no DAC) + Ipamorelin (Blend)?
CJC-1295 without Drug Affinity Complex (no DAC) is a synthetic analog of growth hormone–releasing hormone (GHRH) that stimulates the pituitary gland to naturally release growth hormone (GH) in short, physiologic pulses. Unlike the DAC version, the no DAC form has a much shorter half-life, allowing GH release patterns to more closely mimic the body’s natural rhythm. Ipamorelin is a selective growth hormone secretagogue (GHS) and ghrelin receptor agonist that increases GH secretion without significantly affecting cortisol or prolactin. When studied together, these peptides may have complementary effects on GH output and recovery.
Mechanisms of Action
CJC-1295 (no DAC) + Ipamorelin may work together by:
- CJC-1295 (no DAC): Binding to GHRH receptors to boost GH pulse amplitude and frequency in a short-acting, natural pattern
- Ipamorelin: Activating ghrelin receptors (GHS-R1a) to enhance GH pulses without unwanted hormone spikes
- Increasing circulating IGF-1 to support protein synthesis, tissue repair, and metabolic regulation
- Supporting lean muscle preservation, connective tissue health, and fat metabolism in research models
- Enhancing overall GH output by combining two distinct hormone stimulation pathways
Molecular Structure of Blend Components
CJC-1295 (No DAC) Sequence
Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Ala-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-Gln-Gln-Gly-Glu-Ser
Molecular Properties
CJC-1295 (no DAC) + Ipamorelin (Blend) Research Highlights
CJC‑1295 without DAC is a short-acting analog of GHRH that reproduces the body’s natural growth hormone (GH) pulse patterns, with a half-life of around 30 minutes.
Source: pep-pedia
Its short duration allows for frequent administration that avoids pituitary down-regulation—a key advantage for maintaining physiologic GH sensitivity.
Source: hkroids
Used in conjunction with GHRP peptides like Ipamorelin, CJC‑1295 (no DAC) can enhance GH pulse amplitude and stimulate downstream IGF‑1 signaling for anabolic effects.
Source: thepeptidereport
Clinical and preclinical studies have linked CJC‑1295 (general notes across versions) to increases in GH/IGF‑1, improvements in body composition, sleep, and anti-aging markers—though human data remains limited for No DAC specifically.
Source: peptideinstitute